
Over 20% of Europeans exposed to unhealthy noise pollution – DW – 06/24/2025
More than 100 million people are impacted by transport noise at levels harmful to human health, the environment and economy, says a new EU report.
More than one in five Europeans are exposed to unhealthily high levels of noise pollution from road, rail and aircraft, according to a report today from the European Environment Agency (EEA).
Long-term exposure to the sound of traffic has been connected to a range of health issues, including cardiovascular disease, mental illness, diabetes and premature death.
Children and young people are believed to be particularly vulnerable to its far-reaching impacts, which can include educational performance and weight gain.
The report finds an estimated 112 million people across 31 countries in Europe live with long-term traffic noise louder than the thresholds of 55 dB set by the European Noise Directive. That is equivalent to a residential street or a normal conversation.
The number impacted rises to over 30% of Europeans when measured against stricter World Health Organization recommendations for safe levels of sound.
"Noise pollution is often overlooked, considered just an annoyance of everyday life," said Leena Yla-Mononen, executive director of the EEA, but argued "it's a problem all EU Member States need to urgently address if we are to make progress on our EU 2030 zero pollution target to reduce noise pollution."
The report identified road traffic as the main problem — particularly in crowded urban areas — impacting an estimated 92 million people across the continent.
Only a third of the population in cities assessed have access to quiet, green areas within 400 meters of their homes. Countless studies highlight the health benefits of time spent in nature.
Noise from traffic is the third biggest environmental health threat in Europe, behind air pollution and temperature related factors, according to the report. Across the continent, it results in the annual loss of 1.3 million healthy life years, which the report measures by combining years of life lost due to premature death with those lived in bad health.
Environmental noise and the resulting sleep disturbance can trigger both physical and psychological stress responses associated with metabolic illness, stress and anxiety, disease and cognitive impairment.
The report, which says millions suffer from sleep disturbances resulting from excessive noise, cites 66,000 related premature deaths as well as tens of thousands of cases of cardiovascular disease and type 2 diabetes in Europe each year. It highlights new research pointing at a potential connection to depression and dementia.
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
Too much noise is also taking its toll on the young. The authors say being blasted by the sounds of traffic is causing half a million children to experience reading difficulties and 63,000 to have behavioral challenges. It also draws a connection to more than a quarter of a million overweight young people.
Humans are not the only ones distressed by the din. Wildlife is also being disrupted.
Almost a third of Europe's most threatened and valuable protected nature reserves are at the mercy of roaring traffic. In Europe's waters, the noise of shipping, offshore construction and ocean exploration is impacting marine wildlife. Many species, such as whales and dolphins, rely on sound to survive.
Studies have found that all animal species change their behavior in response to high levels of noise.
Birds such as great tits in cities in Europe, Japan and the UK have been recorded singing higher than their country counterparts, and vocal changes have also been noted in insects, grasshoppers and frogs living near motorways.
Among animal species noise pollution can disrupt mating, the rearing of offspring, and make it harder to locate prey.
Noise pollution is also costing the European economy $95.6 billion (€82.43 billion) annually, through loss of productivity resulting from its health impacts.
While the report focused on Europe, extreme noise can be found in all major cities, from London to Dhaka to Algiers.
In New York, 90% of people using transport are subject to noise that exceeds safety limits and can lead to permanent hearing damage.
Around the world, poorer communities are more likely to be located beside industrial plants, landfills or major traffic arteries, exposing them to more noise than wealthier residents in the same city.
Experts have suggested noise pollution could be eased by reducing traffic, setting lower speed limits, promoting more public transport as well as electric vehicles and cycle paths.
The EEA report says action needs to be taken at both the EU and national level, recommending improved access to quiet and green spaces in cities, as well as measures such as using low noise tires, regular rail maintenance to smooth tracks and optimizing aircraft take-off and landing patterns.
It says without additional regulatory or legislative action, the EU is unlikely to reach existing targets aiming for a 30% reduction in the number of people chronically disturbed by transport noise by 2030.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


DW
20 hours ago
- DW
Germany and COVID-19: What went wrong? – DW – 06/28/2025
The German parliament is seeking to assess the political impact of the COVID-19 pandemic. Former Health Minister Jens Spahn is under attack over the possible misuse of public funds. Jens Spahn, the former German health minister, faced scrutiny this week over the possible misuse of public funds in the large-scale procurement of face masks during the COVID-19 pandemic. He had to answer to questions from the budget committee over why he ordered masks at a very high price and then failed to accept or pay for them. Germany's government could face payments of some €2.3 billion ($2.7 billion) to health-product manufacturers if courts rule against it in the dozens of lawsuits that have been filed over the issue. Spahn has defended his actions, though he admitted last year that he should have done things differently. The heavily redacted version of a report commissioned by Spahn's successor, Karl Lauterbach, was presented to the budget committee of the Bundestag this week. It stated that Spahn's procurement decision was made "against the advice of his specialized departments." The socialist Left Party has called for Spahn to step down from his current role as parliamentary leader of the ruling conservative bloc of Christian Democratic Union and Christian Social Union (CDU/CSU), one of the most powerful positions in the Bundestag. "Anyone who throws our tax money out of the window so carelessly should no longer be allowed to hold an important political office," said Left Party co-leader Ines Schwerdtner. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Germany's governing parties — the CDU/CSU and the center-left Social Democrats (SPD) — have sought to establish an inquiry commission to investigate actions taken by the government during the pandemic, including lockdowns that had a major impact on the country's economy. The Left Party had already suggested such a commission last year. "Firstly, lost trust should be regained through a serious review," read the party's motion put to the parliament. "Secondly, to gain insights and recommendations for action that will help us to deal with the pandemic in a more forward-looking, intelligent and effective way before and during a recurring pandemic situation." Among the supporters of such a commission is Hendrik Streeck, who became known as one of Germany's leading virologists during the pandemic. He went on to win a Bundestag seat for the center-right CDU in Bonn in February this year. The 47-year-old now sits on the parliamentary health committee and is also the federal commissioner for addiction and drug issues. Streeck considers it "absolutely necessary" to re-examine how the pandemic was handled, since it was the biggest health crisis since World War Two, he told DW. Streeck is hoping to get answers to the question of how scientific advice reaches the government in a crisis like the coronavirus pandemic. "This is an area of tension between science, politics and the public," the virologist said. He also wants the new commission to take a critical look at the coordination between the federal and state levels of government. During the pandemic, the leaders of Germany's 16 states convened with the federal government to agree measures such as imposing complete lockdowns. Streeck doubts that this was the best framework, as it meant that the parliament was often relegated to a limited control function. Trained nurse and Left Party Bundestag member Stella Merendino, also a member of the health committee, also wants a review as the basis for lessons to learned for the future. "I experienced the pandemic in a hospital emergency room," she told DW. "I saw people die alone, while we were not allowed to let them see their relatives." The 31-year-old also saw hospital staff collapse from exhaustion and grief. "We worked through shifts without knowing whether we would stay healthy ourselves," she said. "There was no adequate protective equipment, no psychological support, hardly any recognition and, to this day, no systematic evaluation of what this meant for our staff." Merendino also believes that many people were left alone during the pandemic to cope with their economic worries, childcare, and loneliness. "This has fueled anger and mistrust that continues to this day," she said. "We don't have to convince everyone, but we have to listen. And as politicians, we must have the courage to admit mistakes." Above all, Merendino expects to ensure more support for people who are still suffering from the consequences of COVID-19. "I know nursing staff who are no longer able to work because of Long Covid. Many are fighting for recognition, for medical care, for financial security. And all this in a healthcare system that is already overburdened." Meanwhile, Streeck believes that the commission should look beyond Germany's borders for its reappraisal. "More data, more analysis would help us to get a more accurate picture," he said. He is convinced that this would help mitigate the divisions he still sees in society. Streeck says that three groups have formed: "Some who don't want to deal with it. The others who say: We were too lax, we did too little. And the third, who say: We went far too far." Everyone has to be taken seriously, says Streeck. "The best thing that can happen is to talk about it." The review commission could be set up to start its work after the summer break, in September you're here: Every Tuesday, DW editors round up what is happening in German politics and society. You can sign up here for the weekly email newsletter, Berlin Briefing.


DW
4 days ago
- DW
'Miracle' HIV drug lenacapavir approved amid US budget cuts – DW – 06/24/2025
The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections. The battle against HIV has been dealt repeated blows in 2025 with cuts to funding for major global aid programs by the United States. There have also been budget cuts closer to home. And experts have told DW the cuts risk undermining efforts to end the HIV epidemic in the US by 2030, even now, with the approval of lenacapavir — what UNAIDS officials have described as a "miracle" drug — in HIV prevention. Lencapavir provides six months of protection against HIV infection. The renowned journal named it 2024's scientific "breakthrough of the year." Some experts are asking whether the promise of the drug could be undone by the defunding of US public health agencies that are vital for getting lencapavir to those who need it most. "Are we going to squander this, probably the greatest opportunity in 44 years of HIV prevention both in the US and globally?" asked Mitchell Warren, executive director of the nonpartisan HIV organization AVAC, in an interview with DW. Winnie Byanyima, executive director of UNAIDS, the United Nations agency that addresses HIV and AIDS around the world, dubbed lenacapavir a "miracle product" in 2024. If it was hype, it was well-founded hype. In late-stage clinical trials, lenacapavir had a near-perfect record of suppressing HIV infection. Having already approved it as a treatment to reduce viral load in patients with the disease, the US Food and Drug Administration has now confirmed lenacapavir as a pre-exposure prophylaxis (PrEP) drug. PrEP drugs are taken before having unprotected sex or injecting drugs to protect against HIV. Unlike other PrEP drugs, which aim to disrupt the virus at one stage of its life cycle, lencapavir has been shown to attack HIV at several stages, increasing its effectiveness. About 400,000 US patients use some form of PrEP, usually a daily pill. But a twice-a-year injection with lenacapavir would provide people with the longest-lasting protection yet. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video In his first term, US President Donald Trump started an "Ending the HIV Epidemic" (EHE) initiative, an effort to stop the transmission of the disease within the US by the end of this decade. But the current Trump administration's cost-cutting drive has downsized the federal health budget, affecting key public health agencies, such as the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), and programs including Medicare and Medicaid. America's global aid initiatives, including USAID and PEPFAR (the President's Emergency Plan for AIDS Relief), have also been substantially wound back. "Whether it's the NIH research infrastructure [or] USAID for foreign assistance, these are big programs and none of them are HIV specific," Warren said. "But each one of them is diminished now in [its ability] to deliver the comprehensive and integrated programs that have been really at the forefront [of HIV response]." The result of this lost funding, Warren said, is that especially vulnerable groups, such as those from low-income backgrounds, gay and bisexual men and sex workers, may not benefit from the new PrEP drug, lenacapavir, which could provide them with unprecedented protection. Research has found that in US states which have expanded Medicaid coverage to offer health services to "all people with household incomes below a certain level," a growing number of people are using PrEP. Jeffrey Crowley, director of the Center for HIV and Infectious Disease Policy at the O'Neill Institute in Washington, said services like expanded Medicaid coverage have meant better access to HIV programs for those with the disease. "This is an incredible accomplishment, and it's helped drive a lot of the progress we've seen," Crowley told DW. He also said the cuts will mean people lose access to HIV services, which other programs can't cover. "I think the American people can be proud of how we responded to the HIV crisis domestically and globally, but this is all at risk. We've come so far, after so much death, why would we take a step backward?" To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Every year, more than a million new HIV cases are reported globally and, until recently, US support through programs like USAID and PEPFAR was essential in helping regions most affected by the disease, especially countries in Africa. However, the Trump administration's aid withdrawal has already had an impact. Data from UNAIDS suggests there will be 2,300 more HIV cases per year because of the cuts to PEPFAR alone. Annual infections to date were already at about 3,500. "Less funding means we will get more and more off track," said Byanyima in mid-June. "We don't know what the total impact [of the US cuts] will be, but impact there will be. Already, you see in several countries a drop in the number of people going to clinics." The US government continues to support pregnant women and new mothers via PEPFAR, but the changes have stopped access to PrEP for gay and bisexual men, sex workers and drug users — groups that are disproportionately affected by HIV. Warren said it was akin to "throwing out a whole generation" of progress.


DW
4 days ago
- DW
Thailand moves to make recreational cannabis illegal again – DW – 06/25/2025
Three years after decriminalizing cananbis, Thailand is on course to reclassify it as a narcotic, potentially collapsing a $1 billion industry and shutting down thousands of cannabis shops in popular tourist areas. Thailand is set to reclassify cannabis as a narcotic only three years after the country became one of Asia's first to decriminalize its recreational use. Coming in the wake of a government coalition split, the major policy reversal would renew controls on the recreational use of cannabis and shut down a booming $1 billion (€860 million) industry. Thailand removed cannabis from its narcotics list in 2022 but failed to implement a regulatory framework, allowing tens of thousands of cannabis shops to open, many in popular tourist areas. Government spokesman Jirayu Houngsub said the unregulated market has caused social issues, especially among young people. "The policy must return to its original goal of controlling cannabis for medical use only," he said. The decision also comes after the withdrawal of the Bhumjaithai Party — once the main advocate for legalization — from Prime Minister Paetongtarn Shinawatra's ruling coalition. The split followed criticism of Shinawatra's handling of a border dispute with Cambodia. Late Tuesday, the health ministry issued an order banning recreational cannabis sales and requiring a doctor's prescription for any legal purchase. The new regulations will take effect once published in the Royal Gazette, expected in the coming days. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video "Cannabis will be classified as a narcotic in the future," quotes Health Minister Somsak Thepsuthin as saying. The Thai Chamber of Commerce had estimated the industry — covering both recreational and medicinal cannabis — could have been worth $1.2 billion by 2025.